Skip to content
Insider tapeLive · 6:40 PM ET
My stocks
✦ Spy Mode investigation

Sean Edward Quinn's $252K purchase of CACC

CREDIT ACCEPTANCE CORP · Director · filed Nov 16, 2026. Opened Nov 16, 2026, last checked Nov 16, 2026. Waiting for the 7-day result; next check Nov 23, 2026.

Reported value$252K500 shares at $505.00
For this personUnusual1 buy · 0 sales on file
Similar buys beat S&P46%170 cases · all buys 46%

Worth a closer look

  • Open-market purchase with their own money (Form 4 code P), not a grant or option exercise.
  • Raised their own holding by 32%.

Reasons for caution

  • Similar past buys beat the S&P 500 only 46% of the time (170 cases); the typical one trailed it by 1.9%.

What happened after this filing

7 days Pending due Nov 23
30 days Pending due Dec 16
90 days Pending due Feb 14

What we couldn't check

  • Why they traded. Filings don't say, and we don't guess.
  • Company news after the filing, and any private terms.
Summary

Sean Edward Quinn (a director) bought $252K of CACC at about $505.00 on Nov 12, 2026, reported to the SEC on Nov 16, 2026. Buys like this beat the S&P 500 46% of the time since 2020, against 46% for all insider buys. We found 2 points that make it worth a closer look and 1 reason for caution. History, not a prediction.

Share on X Bluesky Reddit
Free PDF · this week

Get this week's insider report

The week's biggest insider buys, every new cluster buy and the stocks to watch, in one printable PDF. Plus the free Monday email.

Please confirm your address from the email we send. Unsubscribe anytime. Not investment advice. Privacy

Written by fixed rules from SEC filings and our measured history, not by an AI model. Public data only. History, not a prediction, and not investment advice.

Other CACC insider trades

Get CACC insider alerts

Choose what you want to hear about. Free.

You'll get an email when a new CACC filing matches your choices (at most one per alert type a day), plus the free Monday email. Already subscribed? Use the same email to add CACC. Unsubscribe anytime. No price targets or advice.

More investigations

All →